Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  Childs:
  - Child:
      Genes: no data
      Label: Lymphomatoid granulomatosis
      ORPHAcode: '86869'
  - Child:
      Genes:
      - Gene:
          ExternalReferences:
          - Reference: '1001'
            Source: HGNC
          - Reference: '109565'
            Source: OMIM
          Label: BCL6 transcription repressor
          Symbol: BCL6
      - Gene:
          ExternalReferences:
          - Reference: '12825'
            Source: HGNC
          - Reference: '602559'
            Source: OMIM
          Label: exportin 1
          Symbol: XPO1
      Label: Primary mediastinal large B-cell lymphoma
      ORPHAcode: '98838'
  - Child:
      Genes:
      - Gene:
          ExternalReferences:
          - Reference: '1001'
            Source: HGNC
          - Reference: '109565'
            Source: OMIM
          Label: BCL6 transcription repressor
          Symbol: BCL6
      - Gene:
          ExternalReferences:
          - Reference: '990'
            Source: HGNC
          - Reference: '151430'
            Source: OMIM
          Label: BCL2 apoptosis regulator
          Symbol: BCL2
      Label: Intravascular large B-cell lymphoma
      ORPHAcode: '98839'
  - Child:
      Genes: no data
      Label: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly
      ORPHAcode: '289661'
  - Child:
      Genes: no data
      Label: Diffuse large B-cell lymphoma of the central nervous system
      ORPHAcode: '300849'
  - Child:
      Genes: no data
      Label: T-cell/histiocyte rich large B cell lymphoma
      ORPHAcode: '300857'
  - Child:
      Genes: no data
      Label: Diffuse large B-cell lymphoma with chronic inflammation
      ORPHAcode: '300888'
  - Child:
      Genes:
      - Gene:
          ExternalReferences:
          - Reference: '427'
            Source: HGNC
          - Reference: '105590'
            Source: OMIM
          Label: ALK receptor tyrosine kinase
          Symbol: ALK
      Label: ALK-positive large B-cell lymphoma
      ORPHAcode: '364043'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377794
    value: Clinical group
  Label: Diffuse large B-cell lymphoma
  ORPHAcode: '544'
  ORPHApacketId: '544'
  PURL: http://www.orpha.net/ORDO/Orphanet_544
  Parents:
  - Parent:
    - Label: Aggressive B-cell non-Hodgkin lymphoma
      ORPHAcode: '300846'
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2018[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: Institut National du Cancer 2013[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Malta
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  Synonyms:
  - Synonym: DLBCL
  TextSection:
    Contents: Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin
      lymphoma (NHL; see this term) in adults characterized by a median age of presentation
      in the sixth decade of life (but also rarely occurring in adolescents and children)
      with the initial presentation being single or multiple rapidly growing masses
      (that may or may not be painful) in nodal or extranodal sites (such as thyroid
      skin breast gastrointestinal tract testes bone or brain) and that can be accompanied
      by symptoms of fever night sweats and weight loss. DLBCL has an aggressive disease
      course with the elderly having a poorer prognosis than younger patients and
      with relapses being common.
    TextSectionType: Definition
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Multigenic/multifactorial
  - TypeOfInheritance:
      value: Not applicable
  copyright: Orphanet (c) 2021
  creationDate: '2021-08-17 17:32:38'
  version: 1.3.7 / 4.1.7 [2020-12-03] (orientdb version)
